Hematologic malignancies and Li–Fraumeni syndrome
Molecular Case Studies · 2019-02 · 5 (1) · a003210
DOI: 10.1101/mcs.a003210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Case Studies, online erschienen am 01.02.2019. Verfasst von Mahesh Swaminathan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA. Hauptthemen laut MEDLINE: Germ-Line Mutation. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Li–Fraumeni syndrome (LFS) is an autosomal dominant condition associated with a high risk of a broad range of childhood- and adult-onset cancers. LFS is related to germline mutations of the tumor-suppressor gene TP53 . The most common reported leukemia associated with LFS is hypodiploid acute lymphoblastic leukemia, but myeloid malignancies including acute myeloid leukemia (AML), chronic myeloid leukemia, and myelodysplastic syndrome (MDS) are also reported, often in the setting of therapy-related disease. We reviewed the clinicopathologic characteristics including cytogenetics and molecular analysis for seven adult patients with LFS and hematologic malignancies evaluated at the Hereditary Hematologic Malignancy Clinic (HHMC) at MD Anderson Cancer Center. We present this LFS review series to increase awareness of LFS for the appropriate diagnosis of both patients and potentially affected relatives, as well as provide experience with patient outcomes in this difficult to treat population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.
- Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.
- Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.
- Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77005, USA.
ORCID-Profile: Koichi Takahashi
Förderung
- NCI NIH HHS
Zitieren
APA
Swaminathan, M., Bannon, S. A., Routbort, M., Naqvi, K., Kadia, T. M., Takahashi, K., Alvarado, Y., Ravandi-Kashani, F., Patel, K. P., Champlin, R., Kantarjian, H., Strong, L., & DiNardo, C. D. (2019). Hematologic malignancies and Li–Fraumeni syndrome. Molecular Case Studies, 5(1), a003210. https://doi.org/10.1101/mcs.a003210
Vancouver
Swaminathan M, Bannon SA, Routbort M, Naqvi K, Kadia TM, Takahashi K, et al. Hematologic malignancies and Li–Fraumeni syndrome. Molecular Case Studies. 2019;5(1):a003210. doi:10.1101/mcs.a003210
BibTeX
@article{Swaminathan2019,
author = {Swaminathan, Mahesh and Bannon, Sarah A and Routbort, Mark and Naqvi, Kiran and Kadia, Tapan M and Takahashi, Koichi and Alvarado, Yesid and Ravandi-Kashani, Farhad and Patel, Keyur P and Champlin, Richard and Kantarjian, Hagop and Strong, Louise and DiNardo, Courtney D},
title = {Hematologic malignancies and Li–Fraumeni syndrome},
journal = {Molecular Case Studies},
year = {2019},
volume = {5},
number = {1},
pages = {a003210},
doi = {10.1101/mcs.a003210}
}
EUVIMED